Anil Chandraker

12.8k total citations · 1 hit paper
194 papers, 9.1k citations indexed

About

Anil Chandraker is a scholar working on Transplantation, Surgery and Immunology. According to data from OpenAlex, Anil Chandraker has authored 194 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Transplantation, 65 papers in Surgery and 64 papers in Immunology. Recurrent topics in Anil Chandraker's work include Renal Transplantation Outcomes and Treatments (75 papers), T-cell and B-cell Immunology (38 papers) and Organ Transplantation Techniques and Outcomes (32 papers). Anil Chandraker is often cited by papers focused on Renal Transplantation Outcomes and Treatments (75 papers), T-cell and B-cell Immunology (38 papers) and Organ Transplantation Techniques and Outcomes (32 papers). Anil Chandraker collaborates with scholars based in United States, Germany and Japan. Anil Chandraker's co-authors include Mohamed H. Sayegh, Leonardo V. Riella, Xueli Yuan, Anita B. Roberts, Julie R. McMullen, Seigo Izumo, Adam L. Dorfman, Elisabeth M. Zeisberg, Oleg Tarnavski and William T. Pu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Anil Chandraker

190 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

2007 1.7k citations Anil Chandraker, Xueli Yuan et al. profile →

Peers

Countries citing papers authored by Anil Chandraker

Since Specialization

Citations

This map shows the geographic impact of Anil Chandraker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Chandraker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Chandraker more than expected).

Fields of papers citing papers by Anil Chandraker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Chandraker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Chandraker. The network helps show where Anil Chandraker may publish in the future.

Co-authorship network of co-authors of Anil Chandraker

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Chandraker. A scholar is included among the top collaborators of Anil Chandraker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Chandraker. Anil Chandraker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant 2024 ·Circulation Cardiovascular Imaging ·Daniel Huck, Brittany Weber, (unknown), (unknown), (unknown), Jon Hainer, Jenifer M. Brown, Sanjay Divakaran, Ron Blankstein, Sharmila Dorbala, Ludovic Trinquart, Anil Chandraker, Marcelo F. Di Carli	2
2	A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection 2024 ·Clinical Transplantation ·Fabian Halleck, Georg A. Böhmig, Lionel Couzi, Lionel Rostaing, Gunilla Einecke, (unknown), Christophe Legendre, Robert A. Montgomery, Peter Hughes, Anil Chandraker, Kate Wyburn, Philip F. Halloran, Angela Q. Maldonado, (unknown), Anna Runström, P. Lefèvre, J Tollemar, Stanley C. Jordan	9
3	Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma 2024 ·Journal of Clinical Oncology ·Glenn J. Hanna, (unknown), Anita Giobbie‐Hurder, (unknown), (unknown), (unknown), Vatche Tchekmedyian, Emily S. Ruiz, (unknown), Chrysalyne D. Schmults, Leonardo V. Riella, Patrick H. Lizotte, Cloud P. Paweletz, Anil Chandraker, Naoka Murakami, Ann W. Silk	29
4	Case Report: Post-transplant lymphoproliferative disorder as a serious complication of vascularized composite allotransplantation 2024 ·SHILAP Revista de lepidopterología ·Alessandra Zaccardelli, Fabienne Lucas, Ann S. LaCasce, Anil Chandraker, Jamil Azzi, Simon G. Talbot	1
5	Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document 2023 ·American Journal of Transplantation ·Carmen Lefaucheur, Kévin Louis, Anna B. Morris, Jean‐Luc Taupin, Peter Nickerson, Anat R. Tambur, Howard M. Gebel, Elaine F. Reed, Jon Kobashigawa, Anil Chandraker, Patricia P. Chang, Monica Colvin, Ramsey R. Hachem, Laurie D. Snyder, Stuart C. Sweet, Deborah J. Levine, Stuart J. Knechtle, Jacqueline G. O’Leary, Joshua Levitsky	38
6	Posoleucel Associated with Reduction of BK Viremia and Persistence of BK-Reactive T Cells in a Phase 2 Trial 2023 ·Journal of the American Society of Nephrology ·Anil Chandraker, (unknown), Reginald Gohh, Akhil Sharma, E. Steve Woodle, Mohammed Javeed Ansari, Vinay Nair, (unknown), Tarek Alhamad, Silas P. Norman, Francesca Cardarelli, Julie Ma, Sarah Gilmore, Spyridoula Vasileiou, David Wojciechowski	1
7	Full facial retransplantation in a female patient—Technical, immunologic, and clinical considerations 2021 ·American Journal of Transplantation ·Martin Kauke‐Navarro, Adriana C. Panayi, Ali‐Farid Safi, Valentin Haug, Bridget J. Perry, Branislav Kollár, Marie‐Christine Nizzi, Justin M. Broyles, Donald J. Annino, Francisco M. Marty, Indranil Sinha, Christine G. Lian, George J. Murphy, Anil Chandraker, Bohdan Pomahač	37
8	High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injury 2020 ·Journal of Translational Medicine ·Shuo Wang, Songjie Cai, Weitao Zhang, (unknown), Yan Li, Chao Zhang, Yigang Zeng, Ming Xu, Ruiming Rong, Tianshu Yang, Benkang Shi, Anil Chandraker, Cheng Yang, Tongyu Zhu	12
9	Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates 2014 ·American Journal of Respiratory and Critical Care Medicine ·Miae Kim, (unknown), Isabelle Wood, Steve Boukedes, Indira Guleria, Steven Gabardi, Souheil El‐Chemaly, Phillip C. Camp, Anil Chandraker, Edgar L. Milford, Hilary J. Goldberg	56
10	Long-Term Outcomes of Kidney Transplantation Across a Positive Complement-Dependent Cytotoxicity Crossmatch 2014 ·Transplantation ·Leonardo V. Riella, Kassem Safa, (unknown), Belinda Lee, Jamil Azzi, Nader Najafian, Reza Abdi, Edgar L. Milford, Helen Mah, Steven Gabardi, Sayeed K. Malek, Stefan G. Tullius, Colm Magee, Anil Chandraker	38
11	The Management of Antibody-Mediated Rejection in the First Presensitized Recipient of a Full-Face Allotransplant 2014 ·American Journal of Transplantation ·Anil Chandraker, Ramon Arscott, George J. Murphy, Christine G. Lian, E.M. Bueno, Francisco M. Marty, Helmut G. Rennke, Edgar L. Milford, Stefan G. Tullius, Bohdan Pomahač	93
12	Combination Therapy With Plasmapheresis, IVIG, and Rituximab Provides Benefit in the Management of Early Antibody Mediated Rejection in Lung Transplant in a Pilot Cohort 2013 ·CHEST Journal ·(unknown), Miae Kim, Isabelle Wood, Steve Boukedes, Indira Guleria, Phillip C. Camp, Souheil El‐Chemaly, Edgar L. Milford, Anil Chandraker, Hilary J. Goldberg	2
13	The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5-Year Allograft Survival 2012 ·American Journal of Transplantation ·(unknown), Vineeta Kumar, Tom A. Williams, Reza Abdi, Andrea J. Bernhardy, Charissa A. Dyer, S Conte, Giulio Genovese, Michael D. Ross, David J. Friedman, Robert S. Gaston, Edgar L. Milford, Martin R. Pollak, Anil Chandraker	133
14	Facial Transplantation and Immunosuppressed Patients 2008 ·Transplantation ·Bohdan Pomahač, (unknown), Anil Chandraker, Julian J. Pribaz	19
15	Pharmacoepidemiology of Anemia in Kidney Transplant Recipients 2004 ·Journal of the American Society of Nephrology ·Wolfgang C. Winkelmayer, Reshma Kewalramani, Mark Rutstein, Steven Gabardi, (unknown), Anil Chandraker	111
16	Fasting Plasma Total Homocysteine Levels and Mortality and Allograft Loss in Kidney Transplant Recipients 2004 ·Journal of the American Society of Nephrology ·Wolfgang C. Winkelmayer, Reinhard Kramar, Gary C. Curhan, Anil Chandraker, Georg Endler, Manuela Födinger, Walter H. Hörl, Gere Sunder‐Plassmann	41
17	The Role of the CD134-CD134 Ligand Costimulatory Pathway in Alloimmune Responses In Vivo 2003 ·The Journal of Immunology ·Xueli Yuan, Alan D. Salama, Victor Dong, (unknown), Nader Najafian, Anil Chandraker, Hisaya Akiba, Hideo Yagita∥, Mohamed H. Sayegh	73
18	Cutting Edge: Recipient MHC Class II Expression Is Required to Achieve Long-Term Survival of Murine Cardiac Allografts After Costimulatory Blockade 2001 ·The Journal of Immunology ·Akira Yamada, Anil Chandraker, Terri M. Laufer, Andrea Gerth, Mohamed H. Sayegh, Hugh Auchincloss	97
19	Human leukocyte antigen matching in renal transplantation: an update 2000 ·Current Opinion in Nephrology & Hypertension ·Nelson Goes, Anil Chandraker	5
20	Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat 1996 ·The Journal of Immunology ·Samia J. Khoury, Lorenzo Gallon, (unknown), Anil Chandraker, Robert Peach, Peter S. Linsley, Laurence A. Turka, Wayne W. Hancock, M H Sayegh	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact